DarioHealth (DRIO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $4.82, -6.04% vs the prior close of $5.13.
- Volume 26.28K shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DRIO slides 6.0% to $4.82, a 52-week low, 3 down days in a row. Closed at $4.82, -6.04% vs the prior close of $5.13. Day range $4.82β$5.40, opened at $5.33.
DRIO daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β DRIO slides 6.0% to $4.82, a 52-week low, 3 down days in a row
- Closed at $4.82, -6.04% vs the prior close of $5.13. Day range $4.82β$5.40, opened at $5.33.
- Volume was 26.28K shares, 1.2x its 50-day average of 22.53K.
- Price is -28.4% vs its 50-day average ($6.74) and -41.0% vs its 200-day average ($8.16).
- 52-week range $4.82β$16.50; today's close sits at 0% of that range, 70.8% below the 52-week high.
- That makes 3 straight losses.
Oct 15, 2026 β DRIO slides 5.9% to $5.13, a 52-week low
- Closed at $5.13, -5.87% vs the prior close of $5.45. Day range $5.03β$5.45, opened at $5.45.
- Volume was 10.30K shares, 0.5x its 50-day average of 22.66K β lighter than usual.
- Price is -24.5% vs its 50-day average ($6.79) and -37.4% vs its 200-day average ($8.19).
- 52-week range $5.03β$16.50; today's close sits at 1% of that range, 68.9% below the 52-week high.
Oct 14, 2026 β DRIO dips 1.6% to $5.45
- Closed at $5.45, -1.62% vs the prior close of $5.54. Day range $5.13β$5.81, opened at $5.49.
- Volume was 6.70K shares, 0.3x its 50-day average of 25.82K β lighter than usual.
- Price is -20.4% vs its 50-day average ($6.85) and -33.7% vs its 200-day average ($8.22).
- 52-week range $5.13β$16.50; today's close sits at 3% of that range, 67.0% below the 52-week high.
Oct 13, 2026 β DRIO rises 2.2% to $5.54
- Closed at $5.54, +2.21% vs the prior close of $5.42. Day range $5.18β$5.54, opened at $5.18.
- Volume was 9.10K shares, 0.4x its 50-day average of 25.84K β lighter than usual.
- Price is -19.4% vs its 50-day average ($6.87) and -32.8% vs its 200-day average ($8.24).
- 52-week range $5.18β$16.50; today's close sits at 3% of that range, 66.4% below the 52-week high.
Oct 12, 2026 β DRIO slides 6.6% to $5.42, a 52-week low
- Closed at $5.42, -6.55% vs the prior close of $5.80. Day range $5.32β$6.36, opened at $6.36.
- Volume was 10.60K shares, 0.4x its 50-day average of 25.77K β lighter than usual.
- Price is -21.5% vs its 50-day average ($6.90) and -34.4% vs its 200-day average ($8.27).
- 52-week range $5.32β$16.50; today's close sits at 1% of that range, 67.2% below the 52-week high.
Oct 9, 2026 β DRIO jumps 6.8% to $5.80
- Closed at $5.80, +6.81% vs the prior close of $5.43. Day range $5.37β$5.85, opened at $5.37.
- Volume was 2.60K shares, 0.1x its 50-day average of 26.05K β lighter than usual.
- Price is -16.4% vs its 50-day average ($6.94) and -30.0% vs its 200-day average ($8.29).
- 52-week range $5.37β$16.55; today's close sits at 4% of that range, 65.0% below the 52-week high.
Oct 8, 2026 β DRIO slides 10.7% to $5.43, a 52-week low
- Closed at $5.43, -10.69% vs the prior close of $6.08. Day range $5.43β$6.05, opened at $6.02.
- Volume was 38.70K shares, 1.5x its 50-day average of 25.51K.
- Price is -22.1% vs its 50-day average ($6.97) and -34.7% vs its 200-day average ($8.31).
- 52-week range $5.43β$16.55; today's close sits at 0% of that range, 67.2% below the 52-week high.
Oct 7, 2026 β DRIO rises 1.0% to $6.08
- Closed at $6.08, +1.00% vs the prior close of $6.02. Day range $5.93β$6.29, opened at $5.93.
- Volume was 2.60K shares, 0.1x its 50-day average of 25.63K β lighter than usual.
- Price is -13.2% vs its 50-day average ($7.00) and -27.1% vs its 200-day average ($8.34).
- 52-week range $5.80β$16.55; today's close sits at 3% of that range, 63.3% below the 52-week high.
Oct 6, 2026 β DRIO jumps 3.8% to $6.02
- Closed at $6.02, +3.79% vs the prior close of $5.80. Day range $5.80β$6.20, opened at $5.80.
- Volume was 7.80K shares, 0.3x its 50-day average of 25.64K β lighter than usual.
- Price is -14.4% vs its 50-day average ($7.03) and -28.1% vs its 200-day average ($8.38).
- 52-week range $5.80β$16.55; today's close sits at 2% of that range, 63.6% below the 52-week high.
Oct 5, 2026 β DRIO slides 10.2% to $5.80, a 52-week low
- Closed at $5.80, -10.22% vs the prior close of $6.46. Day range $5.80β$6.54, opened at $6.53.
- Volume was 26.10K shares, 1.0x its 50-day average of 25.20K.
- Price is -17.9% vs its 50-day average ($7.06) and -31.0% vs its 200-day average ($8.41).
- 52-week range $5.80β$17.74; today's close sits at 0% of that range, 67.3% below the 52-week high.
Oct 2, 2026 β DRIO jumps 4.9% to $6.46
- Closed at $6.46, +4.87% vs the prior close of $6.16. Day range $6.07β$6.61, opened at $6.17.
- Volume was 34.30K shares, 1.4x its 50-day average of 24.74K.
- Price is -9.0% vs its 50-day average ($7.10) and -23.4% vs its 200-day average ($8.44).
- 52-week range $5.84β$17.74; today's close sits at 5% of that range, 63.6% below the 52-week high.
DRIO latest news & SEC filings
Every SEC filing by or about DRIO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 28, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Palumbo John R received an award of 62,000 shares on Sep 24, 2026; now holds 66,500
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Stern Adam K converted 11,760 shares at $40.40 (β$475.10K) on Sep 18, 2025; now holds 17,906
- Stern Adam K converted 8,435 shares at $16.60 (β$140.02K) on Sep 18, 2025; now holds 26,341
- Stern Adam K received an award of 28,000 shares on Sep 24, 2026; now holds 57,717
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Mcgrath Dennis M received an award of 61,000 shares on Sep 24, 2026; now holds 88,737
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Shaked Yoav converted 772 shares at $19.10 (β$14.75K) on Aug 12, 2024; now holds 33,582
- Shaked Yoav received an award of 54,000 shares on Sep 24, 2026; now holds 87,582
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Franco-Yehuda Chen received an award of 95,000 shares on Sep 24, 2026; now holds 125,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Matheis Dennis received an award of 44,000 shares on Sep 24, 2026; now holds 87,026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 4, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Aug 21, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Aug 11, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$7.92M (prior year -$12.99M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: $0.85 (prior year $3.54) (-76.0% vs Jun 30, 2025)
Jul 22, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 8.01 β Reported other events the company considers important.
Jul 22, 2026 Β· Form 424B5 β Prospectus supplement
Prospectus supplement β the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 10, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Things to know before you trade DRIO
- Last results release: Jul 24, 2023 (8-K Item 2.02). Previous ones: Feb 6, 2023, Aug 15, 2022, Jan 19, 2022. Based on that rhythm, the next report is likely around Oct 23, 2023 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.91% (largest 10.7%). That is a volatile stock.
- Liquidity: about 18.97K shares (β$91.43K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $4.82 vs a range of $4.82β$16.50 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:20 on Aug 28, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: Dennis Matheis bought 14,430 shares on Jul 23, 2026.
- Latest filings: 8-K Sep 4, 2026; 8-K Aug 21, 2026; 10-Q Aug 11, 2026.
- Share count: 9.80M shares outstanding (Aug 11, 2026), -78.5% vs a year earlier β the company has been reducing its share count.
- Listing: Nasdaq Β· industry: Surgical & Medical Instruments & Apparatus.
DRIO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 5.33 | 5.40 | 4.82 | 4.82 | 26.28K |
| Oct 15, 2026 | 5.45 | 5.45 | 5.03 | 5.13 | 10.30K |
| Oct 14, 2026 | 5.49 | 5.81 | 5.13 | 5.45 | 6.70K |
| Oct 13, 2026 | 5.18 | 5.54 | 5.18 | 5.54 | 9.10K |
| Oct 12, 2026 | 6.36 | 6.36 | 5.32 | 5.42 | 10.60K |
| Oct 9, 2026 | 5.37 | 5.85 | 5.37 | 5.80 | 2.60K |
| Oct 8, 2026 | 6.02 | 6.05 | 5.43 | 5.43 | 38.70K |
| Oct 7, 2026 | 5.93 | 6.29 | 5.93 | 6.08 | 2.60K |
| Oct 6, 2026 | 5.80 | 6.20 | 5.80 | 6.02 | 7.80K |
| Oct 5, 2026 | 6.53 | 6.54 | 5.80 | 5.80 | 26.10K |
| Oct 2, 2026 | 6.17 | 6.61 | 6.07 | 6.46 | 34.30K |
| Oct 1, 2026 | 6.68 | 6.82 | 6.05 | 6.16 | 56.10K |
| Sep 30, 2026 | 6.76 | 6.91 | 6.62 | 6.62 | 9.30K |
| Sep 29, 2026 | 6.70 | 6.79 | 6.61 | 6.62 | 3.60K |
| Sep 28, 2026 | 6.61 | 6.79 | 6.61 | 6.71 | 8.10K |
| Sep 25, 2026 | 6.77 | 6.82 | 6.61 | 6.63 | 12.70K |
| Sep 24, 2026 | 6.71 | 6.77 | 6.66 | 6.77 | 9.00K |
| Sep 23, 2026 | 6.84 | 6.84 | 6.74 | 6.74 | 1.90K |
| Sep 22, 2026 | 6.98 | 7.12 | 6.71 | 6.89 | 73.50K |
| Sep 21, 2026 | 6.95 | 7.13 | 6.95 | 7.07 | 30.10K |
About DarioHealth
DarioHealth (DRIO) is listed on the Nasdaq and classified by the SEC under βSurgical & Medical Instruments & Apparatusβ. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1533998.
DRIO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Hila Karah | Director | Sep 28, 2026 |
| Dennis M Mcgrath | Director | Sep 28, 2026 |
| Dennis Matheis | Director | Sep 28, 2026 |
| John R Palumbo | Director | Sep 28, 2026 |
| Erez Raphael | Chief Executive Officer | Sep 28, 2026 |
| Adam K Stern | Director | Sep 28, 2026 |
| Yoav Shaked | Director | Sep 28, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Chen Franco-Yehuda | Chief Financial Officer | Sep 28, 2026 |
| Erez Raphael | Chief Executive Officer | Sep 28, 2026 |
| Lara Ann Sherman | Chief Operating Officer | Sep 28, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 23, 2026 | Dennis Matheis | Buy | 14,430 | $6.93 |
| Jul 23, 2026 | Dennis Matheis | Buy | 14,430 | $6.93 |
| Jul 23, 2026 | Dennis Matheis | Buy | 14,430 | $6.93 |
| Jul 23, 2026 | Dennis Matheis | Buy | 14,430 | $6.93 |
DRIO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | β | $-41.71M | 10.12 | $-25.94M |
| Dec 31, 2024 | β | $-42.75M | 12.27 | $-38.56M |
| Dec 31, 2023 | β | $-59.43M | 1.93 | $-30.38M |
| Dec 31, 2022 | β | $-62.19M | 2.54 | $-47.84M |
| Dec 31, 2021 | β | $-76.76M | 4.07 | $-50.41M |
Latest balance sheet: total assets $96.59M, total liabilities $β, cash $6.63M (as of Jun 30, 2026).
DRIO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 24, 2023 | 8-K Item 2.02 (results) | β |
| Feb 6, 2023 | 8-K Item 2.02 (results) | β |
| Aug 15, 2022 | 8-K Item 2.02 (results) | β |
| Jan 19, 2022 | 8-K Item 2.02 (results) | β |
| Aug 16, 2021 | 8-K Item 2.02 (results) | β |
Related stocks Β· Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on DRIO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.